Michael Sofia
2017
In 2017, Michael Sofia earned a total compensation of $846.8K as Chief Scientific Officer at Arbutus Biopharma Corp, a 12% increase compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $334,500 |
| Salary | $350,000 |
| Other | $12,333 |
| Total | $846,833 |
Sofia received $350K in salary, accounting for 41% of the total pay in 2017.
Sofia also received $150K in bonus, $334.5K in option awards and $12.3K in other compensation.
Rankings
In 2017, Michael Sofia's compensation ranked 9,782nd out of 14,666 executives tracked by ExecPay. In other words, Sofia earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,782 out of 14,666 | 33rd |
Division Manufacturing | 3,778 out of 5,768 | 35th |
Major group Chemicals And Allied Products | 1,310 out of 2,074 | 37th |
Industry group Drugs | 1,057 out of 1,730 | 39th |
Industry Pharmaceutical Preparations | 830 out of 1,329 | 38th |
Source: SEC filing on April 25, 2018.
Sofia's colleagues
We found four more compensation records of executives who worked with Michael Sofia at Arbutus Biopharma Corp in 2017.
News
Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
April 10, 2024
Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
April 12, 2023
Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
April 11, 2022
Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
April 8, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020